Kck Ltd. - Net Worth and Insider Trading

Kck Ltd. Net Worth

The estimated net worth of Kck Ltd. is at least $43 Million dollars as of 2024-05-24. Kck Ltd. is the 10% Owner of NeuroPace Inc and owns about 5,593,773 shares of NeuroPace Inc (NPCE) stock worth over $43 Million. Kck Ltd. is also the 10% Owner of Aileron Therapeutics Inc and owns about 32,341 shares of Aileron Therapeutics Inc (ALRN) stock worth over $118,368. Details can be seen in Kck Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kck Ltd. has not made any transactions after 2023-12-01 and currently still holds the listed stock(s).

Transaction Summary of Kck Ltd.

To

Kck Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kck Ltd. owns 3 companies in total, including Aileron Therapeutics Inc (ALRN) , NeuroPace Inc (NPCE) , and Sight Sciences Inc (SGHT) .

Click here to see the complete history of Kck Ltd.’s form 4 insider trades.

Insider Ownership Summary of Kck Ltd.

Ticker Comapny Transaction Date Type of Owner
ALRN Aileron Therapeutics Inc 2017-07-05 10 percent owner
NPCE NeuroPace Inc 2023-12-01 10 percent owner
SGHT Sight Sciences Inc 2021-07-14 10 percent owner

Kck Ltd. Latest Holdings Summary

Kck Ltd. currently owns a total of 2 stocks. Among these stocks, Kck Ltd. owns 5,593,773 shares of NeuroPace Inc (NPCE) as of December 1, 2023, with a value of $43 Million and a weighting of 99.72%. Kck Ltd. also owns 32,341 shares of Aileron Therapeutics Inc (ALRN) as of July 5, 2017, with a value of $118,368 and a weighting of 0.28%.

Latest Holdings of Kck Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NPCE NeuroPace Inc 2023-12-01 5,593,773 7.60 42,512,675
ALRN Aileron Therapeutics Inc 2017-07-05 32,341 3.66 118,368

Holding Weightings of Kck Ltd.


Kck Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Kck Ltd. has made a total of 2 transactions in NeuroPace Inc (NPCE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in NeuroPace Inc is the sale of 16,167 shares on December 1, 2023, which brought Kck Ltd. around $141,946.

According to the SEC Form 4 filings, Kck Ltd. has made a total of 0 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 10,000 shares on July 5, 2017, which cost Kck Ltd. around $3 Million.

Insider Trading History of Kck Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kck Ltd. Trading Performance

GuruFocus tracks the stock performance after each of Kck Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kck Ltd. is 18.28%. GuruFocus also compares Kck Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Kck Ltd. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kck Ltd.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kck Ltd.

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.38
Relative Return to S&P 500(%) -3.2

Kck Ltd. Ownership Network

Ownership Network List of Kck Ltd.

No Data

Ownership Network Relation of Kck Ltd.


Kck Ltd. Owned Company Details

What does Aileron Therapeutics Inc do?

Who are the key executives at Aileron Therapeutics Inc?

Kck Ltd. is the 10 percent owner of Aileron Therapeutics Inc. Other key executives at Aileron Therapeutics Inc include See Remarks James Brian Windsor , See Remarks Susan L. Drexler , and 10 percent owner Muneer A Satter .

Aileron Therapeutics Inc (ALRN) Insider Trades Summary

Over the past 18 months, Kck Ltd. made no insider transaction in Aileron Therapeutics Inc (ALRN). Other recent insider transactions involving Aileron Therapeutics Inc (ALRN) include a net sale of 51,466 shares made by , and a net purchase of 5,301 shares made by James Brian Windsor .

In summary, during the past 3 months, insiders sold 51,466 shares of Aileron Therapeutics Inc (ALRN) in total and bought 0 shares, with a net sale of 51,466 shares. During the past 18 months, 51,466 shares of Aileron Therapeutics Inc (ALRN) were sold and 5,301 shares were bought by its insiders, resulting in a net sale of 46,165 shares.

Aileron Therapeutics Inc (ALRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aileron Therapeutics Inc Insider Transactions

No Available Data

Kck Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Kck Ltd.. You might contact Kck Ltd. via mailing address: Craigmuir Chambers, Road Town, Tortola D8 Vg1110.

Discussions on Kck Ltd.

No discussions yet.